SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Attack II - A Complete Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Paul Shread who wrote (1988)3/5/2001 2:44:18 PM
From: adcpres  Read Replies (1) | Respond to of 52237
 
Paul: There may not be much "fresh" money. People may have to pull money out if things don't improve to pay for all thoses houses, cars, etc. they purchased when they felt and looked rich on paper last year. GH



To: Paul Shread who wrote (1988)3/5/2001 3:01:06 PM
From: donald sew  Read Replies (2) | Respond to of 52237
 
Paul,

>>>> Here's a thought: what if tech stocks don't lead the next bull market (whenever that comes)? <<<<

Didn't technology, going back to the railroads mainly lead the bull markets?

Regardless, heres a scarey thought for those NAZ bulls, what if the NAZ returns back to old days when daily oscillations of 50-75 points were large.



To: Paul Shread who wrote (1988)3/5/2001 3:29:39 PM
From: Jack T. Pearson  Read Replies (1) | Respond to of 52237
 
The stocks that will lead the next bull market will be the stocks with the best "expected" growth in sales and earnings. IMHO, the leaders will be companies that meet two criteria: 1) They take full advantage of new technology or business models to cut costs, provide additional value, or speed time to market, and 2) They rapidly adapt to the current business climate (avoid deep financial trouble, keep key personnel, prune their product lines of weak products, and continue development of new products). I don't think the next bull market will be as innovative and economy-transforming as the last. I believe the premium will be on execution rather than innovation (Biotech may be the exception here).